Pioneer in data science
For over 20 years, we have been supporting healthcare industry players and institutions to unlock the full potential of health data.
Early access
A qualified team and dedicated tools
Real-world evidence studies
Proven experience and diversified data sources
Health data analysis
Advanced data science technologies expertise
Digital solutions
We analyze your health data
Types of studies
Study objectives
Expertise
● Scientific and medical
Data sources
● Ad hoc data collection
● Medico-administrative databases (SNDS, PMSI...) / FREiA
● Medical registries
● Biology data, anapath
● Health data warehouses
Leader in healthcare data since 2005.
Founded in 2005, Heva, leading player in public health data (PMSI, SNDS) joined Docaposte in 2022 and became a brand of La Poste Santé & Autonomie. This affiliation enables Heva to broaden its scope of action and strengthen its capacity to develop sovereign digital tools.
Heva then added the expertise of Inadvans and Axonal-Biostatem, in 2025. Thanks to these acquisitions, Heva is now in a position to support its customers across the entire healthcare data value chain, from collection to analysis and the delivery of results for pharmaceutical industry, medical device sector, biotechnology companies, and health sector institutions.
Our figures keys
Top 3
research companies in clinical studies
+100
customers : Pharma / medtech/ biotech and institutional stakeholders
~20
data partners in France and abroad
63
publications, 45 posters, 12 oral communications, 6 articles in 2024
15
evaluations (Article 51 certified by ARS/DGS)
We are members of 3 think tanks
Formation – Jeudi 5 février
Utiliser les données de vie réelle pour répondre à vos enjeux stratégiques
L’objectif de cette formation est de présenter les données disponibles
en France (accès, structure, forces, limites), la méthodologie des
études observationnelles et les applications possibles.
News on our networks
Discover Heva's latest news and reflections on the challenges facing the healthcare sector. Stay informed and anticipate future developments.
